Close Menu

NEW YORK — The US Food and Drug Administration last week reissued an Emergency Use Authorization for a PCR-based SARS-CoV-2 test from the Broad Institute to expand the types of samples it may use.

The agency also issued a new EUA for a SARS-CoV-2 immunoassay developed by Celltrion.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.